The Latest Cardiac and Vascular News
MILWAUKEE, July 1, 2020 /PRNewswire/ — Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Dr. Daniel O’Hair as its Chief Medical Officer. For more than 20 years Dr. Daniel O’Hair has practiced as a Cardiovascular Surgeon, thought leader and scientific innovator […]
GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company’s new General Manager for Americas. Thanos’ appointment will play a critical role in supporting Mentice’s continual growth strategy and will help accelerate its leadership position in high fidelity endovascular simulation solutions. Vice President […]
New Guidelines Consistent with Silk Road Medical Certification Process SUNNYVALE, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the In-Press release of a clinical competence statement on training and credentialing for TransCarotid […]
Former President and CEO of the North American division of AstraZeneca Plc to join as Independent Director Westport, CT, July 01, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity […]
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that pooled efficacy analysis from the four Phase 3 clinical studies of NEXLETOL, an oral, once-daily LDL-cholesterol lowering medicine, was published in the Journal of the American Medical Association (JAMA) Cardiology. The four Phase 3 clinical studies […]
– Topline data from ENHANCE-IT study of MAT9001 vs. Vascepa® expected in Q1 2021 – – EnACT remains on track for cohort progression in Q4 2020 – BEDMINSTER, N.J., June 30, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has commenced enrollment and started dosing […]
First Site Initiation Visit in Trial Completed and Executive Steering Committee Named SAN CARLOS, Calif., July 01, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced activation of a pivotal trial studying the Company’s investigational CardiAMP® cell therapy in the treatment of […]
Dr. Brajesh Lal of the University of Maryland Presents Study Data at the Society for Vascular Surgery Conference July 01, 2020 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Elucid Bio, maker of the FDA-cleared and CE-marked vascuCAP® software, announced today that its novel artificial intelligence (AI) technology demonstrated an over 70 […]
BURLINGTON, Mass.–(BUSINESS WIRE)–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has resubmitted its 505(b)(2) New Drug Application (NDA) to the U.S. Food and […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that it intends to offer and sell, subject to market and other conditions, $400 million of its common stock in an […]
